Publications by authors named "Tal Zaks"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,471,590

Total Likes

32,263

Extended Reach

15,981,299

Social Features

447
R
Report of the European Medicines Agency Conference on RNA-Based Medicines.
Falk Ehmann, Andreas Kuhn, Anna Maria Gerdina Pasmooij, Anthony Humphreys, Arjon Van Hengel, Tal Zaks

Nucleic Acid Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study.
Jeffrey S Weber, Matteo S Carlino, Adnan Khattak, Tarek Meniawy, George Ansstas, Tal Zaks

Lancet· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Development of mRNA Vaccines: Challenges and Opportunities.
Allison August, Luis Brito, Robert Paris, Tal Zaks

Curr Top Microbiol Immunol· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
Kapil Bahl, Joe J Senn, Olga Yuzhakov, Alex Bulychev, Luis A Brito, Tal Zaks

Mol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and Immunogenicity of an mRNA-Based Human Metapneumovirus and Parainfluenza Virus Type 3 Combined Vaccine in Healthy Adults.
Allison August, Christine A Shaw, Heather Lee, Conor Knightly, Shiva Kalidindia, Tal Zaks

Open Forum Infect Dis· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
Allison August, Husain Z Attarwala, Sunny Himansu, Shiva Kalidindi, Sophia Lu, Tal Zaks

Nat Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1 trial of lipid-encapsulated mRNA encoding a monoclonal antibody with neutralizing activity against Chikungunya virus.
Allison August, Husain Z Attarwala, Sunny Himansu, Shiva Kalidindi, Sophia Lu, Tal Zaks

Nat Med· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
Amarendra Pegu, Sarah E O'Connell, Stephen D Schmidt, Sijy O'Dell, Chloe A Talana, Tal Zaks

Science· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for Cancer.
Amir Massarweh, Noa Eliakim-Raz, Amos Stemmer, Adva Levy-Barda, Shlomit Yust-Katz, Tal Zaks

JAMA Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid nanoparticles for mRNA delivery.
Xucheng Hou, Tal Zaks, Robert Langer, Yizhou Dong

Nat Rev Mater· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA-encoded, constitutively active STING is a potent genetic adjuvant of antigen-specific CD8 T cell response.
Sze-Wah Tse, Kristine McKinney, William Walker, Mychael Nguyen, Jared Iacovelli, Tal Zaks

Mol Ther· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 1, randomized, placebo-controlled study to evaluate the safety and immunogenicity of an mRNA-based RSV prefusion F protein vaccine in healthy younger and older adults.
Antonios O Aliprantis, Christine A Shaw, Paul Griffin, Nicholas Farinola, Radha A Railkar, Tal Zaks

Hum Vaccin Immunother· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer.
Gal Cafri, Jared J Gartner, Tal Zaks, Kristen Hopson, Noam Levin

J Clin Invest· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials.
Robert A Feldman, Rainard Fuhr, Igor Smolenov, Amilcar Mick Ribeiro, Lori Panther, Tal Zaks

Vaccine· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical and Clinical Demonstration of Immunogenicity by mRNA Vaccines against H10N8 and H7N9 Influenza Viruses.
Kapil Bahl, Joe J Senn, Olga Yuzhakov, Alex Bulychev, Luis A Brito, Tal Zaks

Mol Ther· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-specific, histology-independent, randomized discontinuation study of lapatinib in patients with HER2-amplified solid tumors.
Matthew D Galsky, Daniel D Von Hoff, Marcus Neubauer, Thomas Anderson, Mark Fleming, Tal Z Zaks

Invest New Drugs· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study to evaluate the efficacy and safety of neoadjuvant lapatinib plus paclitaxel in patients with inflammatory breast cancer.
Hamouda Boussen, Massimo Cristofanilli, Tal Zaks, Michelle DeSilvio, Vanessa Salazar

J Clin Oncol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Target-specific randomized discontinuation trial design: a novel approach in molecular therapeutics.
Matthew D Galsky, Tal Zaks, Habib Hassani, Linda Vocila, Guru Sonpavde

Invest New Drugs· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II multicenter trial of two schedules of lapatinib as first- or second-line monotherapy in patients with advanced or metastatic non-small cell lung cancer.
Helen J Ross, George R Blumenschein, Joseph Aisner, Nevena Damjanov, Afshin Dowlati, Tal Z Zaks

Clin Cancer Res· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases.
Fawn Qian, Stefan Engst, Kyoko Yamaguchi, Peiwen Yu, Kwang-Ai Won, Tal Zaks

Cancer Res· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lapatinib monotherapy in patients with HER2-overexpressing relapsed or refractory inflammatory breast cancer: final results and survival of the expanded HER2+ cohort in EGF103009, a phase II study.
Bella Kaufman, Maureen Trudeau, Ahmad Awada, Kimberly Blackwell, Thomas Bachelot, Tal Zaks

Lancet Oncol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide DNA copy number predictors of lapatinib sensitivity in tumor-derived cell lines.
Joel Greshock, Jie Cheng, David Rusnak, Anne Marie Martin, Richard Wooster, Tal Zaks

Mol Cancer Ther· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of predictive biomarker profiles for response targeting human epidermal growth factor receptor 2 (HER-2) in advanced inflammatory breast cancer with lapatinib monotherapy.
Stephen Johnston, Maureen Trudeau, Bella Kaufman, Hamouda Boussen, Kimberley Blackwell, Tal Z Zaks

J Clin Oncol· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer cell lines as genetic models of their parent histology: analyses based on array comparative genomic hybridization.
Joel Greshock, Katherine Nathanson, Anne-Marie Martin, Lin Zhang, George Coukos, Tal Z Zaks

Cancer Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis